Detalhe da pesquisa
1.
A prospective observational study of effectiveness and safety of iron isomaltoside in patients with chronic renal failure and iron deficiency anemiaâ©.
Clin Nephrol
; 86 (2016)(12): 310-318, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27737531
2.
Efficacy of lipid reduction with DALI and MONET.
Atheroscler Suppl
; 30: 217-224, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29096841
3.
Safety aspects of lipidapheresis using DALI and MONET - Multicenter observational study.
Atheroscler Suppl
; 30: 225-231, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29096842
4.
New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk.
Wien Klin Wochenschr
; 126(5-6): 169-75, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24615676
5.
Monthly continuous erythropoietin receptor activator treatment maintains stable hemoglobin levels in routine clinical management of hemodialysis patients.
Hemodial Int
; 16(1): 11-9, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22098689
6.
Monthly administration of a continuous erythropoietin receptor activator provides efficient haemoglobin control in non-dialysis patients during routine clinical practice: results from the non-interventional, single-cohort, multicentre, SUPRA study.
Clin Drug Investig
; 32(2): 99-110, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22117178